Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with EMATE, a dual inhibitor of carbonic anhydrases and steroid sulfatase

被引:145
作者
Abbate, F
Winum, JY
Potter, BVL
Casini, A
Montero, JL
Scozzafava, A
Supuran, CT
机构
[1] Univ Florence, Dipartimento Chim, Lab Chim Bioinorgan, I-50019 Florence, Italy
[2] Univ Montpellier 2, Lab Chim Biomol, Ecole Normal Super Chim Montpellier, UMR 5032, F-34296 Montpellier, France
[3] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England
[4] Univ Bath, Sterix Ltd, Bath BA2 7AY, Avon, England
关键词
D O I
10.1016/j.bmcl.2003.09.064
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The X-ray crystal structure for the adduct of human carbonic anhydrase II (hCA II) with estrone-3-O-sulfamate (EMATE), an antiendocrine agent showing both CA and estrone sulfatase inhibitory properties, has been resolved at a resolution of 1.5 Angstrom. Its binding to the enzyme is similar to that of other sulfamates/sulfonamides, considering the interactions of the zinc anchoring group, but differs considerably when the steroidal scaffold of the inhibitor is analyzed. This part of the inhibitor interacts only within the hydrophobic half of the CA active site, interacting with residues Val 121, Phe 131, Val 135 and Pro 202, and leaving the hydrophilic half able to accommodate several water molecules not present in the uncomplexed enzyme. In addition, a very short bond of 1.78 Angstrom between the zinc ion and the coordinated nitrogen atom of the sulfamate moiety is observed, which may explain the high affinity of this inhibitor for hCA II (K-i of 10 nM). (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:231 / 234
页数:4
相关论文
共 37 条
[1]   Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with the perfluorobenzoyl analogue of methazolamide. Implications for the drug design of fluorinated inhibitors [J].
Abbate, F ;
Casini, A ;
Scozzafava, A ;
Supuran, CT .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2003, 18 (04) :303-308
[2]   Nonaromatic sulfonamide group as an ideal anchor for potent human carbonic anhydrase inhibitors: Role of hydrogen-bonding networks in ligand binding and drug design [J].
Abbate, F ;
Supuran, CT ;
Scozzafava, A ;
Orioli, P ;
Stubbs, MT ;
Klebe, G .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (17) :3583-3587
[3]   Review of estrone sulfatase and its inhibitors - An important new target against hormone dependent breast cancer [J].
Ahmed, S ;
Owen, CP ;
James, K ;
Sampson, L ;
Patel, CK .
CURRENT MEDICINAL CHEMISTRY, 2002, 9 (02) :263-273
[4]  
Beasley NJP, 2001, CANCER RES, V61, P5262
[5]   Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with a bis-sulfonamide - Two heads are better than one? [J].
Casini, A ;
Abbate, F ;
Scozzafava, A ;
Supuran, CT .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (16) :2759-2763
[6]   Carbonic anhydrase inhibitors:: SAR and x-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with Isozymes I, II and IV [J].
Casini, A ;
Antel, J ;
Abbate, F ;
Scozzafava, A ;
David, S ;
Waldeck, H ;
Schäfer, S ;
Supuran, CT .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (05) :841-845
[7]   Sulfonamides and Sulfonylated Derivatives as Anticancer Agents [J].
Casini, Angela ;
Scozzafava, Andrea ;
Mastrolorenzo, Antonio ;
Supuran, Claudiu T. .
CURRENT CANCER DRUG TARGETS, 2002, 2 (01) :55-75
[8]  
Chegwidden WR, 2001, GENE FAMILIES STUDIE, P157
[9]   Nonsteroidal compounds designed to mimic potent steroid sulfatase inhibitors [J].
Ciobanu, LC ;
Luu-The, V ;
Poirier, D .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2002, 80 (03) :339-353
[10]   Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, cancer-associated isozyme IX with lipophilic sulfonamides [J].
Franchi, M ;
Vullo, D ;
Gallori, E ;
Pastorek, J ;
Russo, A ;
Scozzafava, A ;
Pastorekova, S ;
Supuran, CT .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2003, 18 (04) :333-338